Many different groups and individuals contributed to the consultations on amendments to the directive carried out in 2007. The majority of private individuals who responded were in favour of ending the use of supplementary indications. However, without exception the European and American industry federations and individual firms who responded were in favour of retaining supplementary indications for another ten years or indefinitely. They pointed to conflicting federal law in the United States that would have necessitated relabelling. All member states who responded were also in favour of extending supplementary indications.